Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

OTHER 21NETWORK 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 7Gynecologic 4Other 3Thoracic 2Genitourinary 2CNS 2Sarcoma 1Lymphoid 1Classical hematology 1

Conditions

Carcinoma, Non-Small-Cell Lung 168Lung Neoplasms 148Adenocarcinoma of Lung 37Small Cell Lung Carcinoma 23Adenocarcinoma, Bronchiolo-Alveolar 20Breast Neoplasms 15Mesothelioma, Malignant 13Colorectal Neoplasms 11Colonic Neoplasms 10Prostatic Neoplasms 9Rectal Neoplasms 7Ovarian Neoplasms 7Breast Neoplasms, Male 7Neoplasm Metastasis 6Melanoma 6Carcinoma, Ovarian Epithelial 6Thymoma 5Pleural Effusion, Malignant 5Stomach Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Pain 4Neoplasms 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Salivary Gland Neoplasms 3Lymphoma, Large B-Cell, Diffuse 3Head and Neck Neoplasms 3Fallopian Tube Neoplasms 3Esthesioneuroblastoma, Olfactory 3Esophageal Neoplasms 3

Interventions

Paclitaxel 2Carboplatin 2Radiotherapy 1Filgrastim 1Cetuximab 1Amifostine 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Radiation Injuries × Thoracic × Clear all
NCT00533949 2022-06-21

High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Radiation Therapy Oncology Group

Phase 3 Completed
544 enrolled 21 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Radiation Injuries

NCT00003313 2014-11-21

Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer

Radiation Therapy Oncology Group

Phase 3 Completed
243 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Radiation Injuries, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡